Modulating glial genes involved in synaptic function mitigates pathogenesis and behavioral deficits in a<i>Drosophila</i>model of Huntington’s Disease

Tarik S. Onur,Andrew Laitman,He Zhao,Ryan Keyho,Hyemin Kim,Jennifer Wang,Megan Mair,Alma Perez,Maria de Haro,Huilan Wang,Ying-Wooi Wan,Genevera Allen,Boxun Lu,Ismael Al-Ramahi,Zhandong Liu,Juan Botas
DOI: https://doi.org/10.1101/2020.11.03.367326
2020-01-01
Abstract:AbstractMost research on neurodegenerative diseases has focused on neurons, yet glia help form and maintain the synapses whose loss is so prominent in these conditions. To investigate the contributions of glia to Huntington’s disease (HD), we studied transcriptomic changes in HD human, HD mice, andDrosophilaexpressing human mutantHuntingtin(mHTT) in either glia, neurons or both. A large portion of conserved genes are concordantly dysregulated across the three species; we tested these genes in a high-throughput behavioral assay and found that downregulation of genes involved in synapse assembly mitigated pathogenesis and behavioral deficits. To our surprise, mitigating glial pathogenesis by dNRXN3knockdown was sufficient to improve the phenotype of flies expressing mHTTin neurons, suggesting that mHTT’s toxic effects in glia ramify throughout the brain. This supports a model in which dampening synaptic function is protective because it attenuates the excitotoxicity that characterizes HD.
What problem does this paper attempt to address?